Drug Information

Drug General Information
Drug ID
D02ZPZ
Former ID
DNC003712
Drug Name
5-((E)-Styryl)-quinazoline-2,4-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533781]
Formula
C16H14N4
Canonical SMILES
C1=CC=C(C=C1)C=CC2=C3C(=CC=C2)N=C(N=C3N)N
InChI
1S/C16H14N4/c17-15-14-12(10-9-11-5-2-1-3-6-11)7-4-8-13(14)19-16(18)20-15/h1-10H,(H4,17,18,19,20)/b10-9+
InChIKey
YPIDSPOROIRHIL-MDZDMXLPSA-N
PubChem Compound ID
6532431
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [533781]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 533781J Med Chem. 1995 Mar 3;38(5):745-52.2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
Ref 533781J Med Chem. 1995 Mar 3;38(5):745-52.2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.